[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Eugene Science, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

September 2019 | 50 pages | ID: EB03657B4F3BEN
BAC Reports

US$ 499.00

Email Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Eugene Science, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Eugene Science, Inc. and its competitors. This provides our Clients with a clear understanding of Eugene Science, Inc. position in the Industry Industry.

  • The report contains detailed information about Eugene Science, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Eugene Science, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Eugene Science, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Eugene Science, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Eugene Science, Inc. business.

About Eugene Science, Inc.

Eugene Science, Inc., a biotechnology company, engages in the development, manufacture, and marketing of nutraceuticals, or functional foods that offer health promoting advantages beyond that of nutrition.


Plant Sterol and Cholesterol-Reduction Products

The company has developed and patented a series of cholesterol-lowering food additives, consisting of specially formulated plant sterols that are soluble in both oil and water. The key technology to produce such plant sterols is a patented nanotechnology which allows plant sterols to be added to a range of oil and water-based foods. The company’s nano-sized plant sterols used as food additives are branded as ‘CZ-series’ additives and its food and consumable products containing CZ-series additives are being marketed under the brand name of ‘CholZero.’ The company’s initial CholZero-branded products include CholZero capsules containing its CZ-S Series additive and a CholZero beverage.

The company produces various specific plant sterol food ingredients, including CZ-L, an oil soluble plant sterol and fatty acid; CZ-S, a water dispersible natural plant sterol; and CZ-H, a water-soluble CZ-series additive.

Liphophilic Quality - CZ-L

CZ-L is a plant sterol in ester form that is soluble in oil and fat. CZ-L may be added to foods with a significant fat content and does not influence the taste or flavor of such foods.

Water Dispersible Plant Sterol - CZ-S

CZ-S is a water dispersible plant sterol. Prior to the development of its CZ-S products, only fat soluble plant sterol food additives were available to consumers. CZ-S would be used to integrate plant sterol into beverages, dairy products, and other water based foods. CZ-S comes in the form of a water dispersible powder that makes very fine micelles in an aqueous solution. Like CZ-L, CZ-S does not influence the taste and flavor of the food or beverage to which it is added.

Next Generation - CZ-H

CZ-H is also a plant sterol in ester form that is water soluble and transparent in water. Like the other CZ Series ingredients, CZ-H has a cholesterol lowering effect upon ingestion by blocking the absorption of cholesterol in the intestines and be added to water based products.

Supplemental Products

In addition to its CZ Series and CholZero branded products, the company distributes DG Oil, functional cooking oil with a body fat lowering effect manufactured by OnBio Corporation, animal feed, pet shampoo, and deodorant in South Korea. It obtained its raw cooking oil pursuant to a contract with a South Korean supplier. The company has an approximately 73% ownership interest in UcoleBio Corp., a company formed to provide sales and distribution services for its products in Korea.


The company has operations in Korea, Japan, Taiwan, North America, and Europe.


The company’s customers include Nutra Nano Tech, Amway Korea, and OnBio Corporation.


Functional Foods: The company competes with Benecol (Raisio's joint venture with Johnson & Johnson); Take Control (Unilever); Aviva Heart Benefits (Novartis); Cheerios (General Mills); Ensemble (Kellogg); Health Source (Ross Products Division of Abbott Laboratories); and Quaker Oats (Quaker Oat Company).

Dietary Supplements: The company competes with LO-CHOL (Applied Plant Pharmaceuticals, Inc.); Cholestin (Pharmanex); Kholestrol Blocker (Nutrition For Life International); EvolvE (Bionutrics); Kwai (Lichtwer Pharma); and Metamucil (Procter & Gamble).


Eugene Science, Inc. was founded in 1997.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. Eugene Science, Inc. Direct Competitors
5.2. Comparison of Eugene Science, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Eugene Science, Inc. and Direct Competitors Stock Charts
5.4. Eugene Science, Inc. Industry Analysis
  5.4.1. Industry Industry Snapshot
  5.4.2. Eugene Science, Inc. Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





Eugene Science, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Eugene Science, Inc. 1-year Stock Charts
Eugene Science, Inc. 5-year Stock Charts
Eugene Science, Inc. vs. Main Indexes 1-year Stock Chart
Eugene Science, Inc. vs. Direct Competitors 1-year Stock Charts
Eugene Science, Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.


Eugene Science, Inc. Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Eugene Science, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Eugene Science, Inc. Major Shareholders
Eugene Science, Inc. History
Eugene Science, Inc. Products
Revenues by Segment
Revenues by Region
Eugene Science, Inc. Offices and Representations
Eugene Science, Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Eugene Science, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Eugene Science, Inc. Capital Market Snapshot
Eugene Science, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Industry Industry Statistics
Eugene Science, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Eugene Science, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?

More Publications